| Ytd | -3.68% | |
| 1y | -22.29% |
| Open | 20.51 | Prev Close | 20.24 | Low | 19.08 | High | 20.80 | Mkt Cap | 5.29B |
| Vol | 557.64K | Avg Vol | 388.97K | EPS | 0.57 | P/E | 34.00 | Forward P/E | 23.42 |
| Beta | 0.78 | Short Ratio | 3.04 | Inst. Own | 102.95% | Dividend | 0.06 | Div Yield | 0.30 |
| Ex Div Date | 06-11 | Earning | 11-03 | 50-d Avg | 20.64 | 200-d Avg | 18.11 | 1yr Est | 24.84 |
The Conestoga Small Cap Composite returned -11.22% net of fees in 3Q26, trailing the -9.39% return f
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) (the “Company”), a leadin
The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third qua
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provide
Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tr
UBS analyst Dan Leonard maintains Stevanato Group (NYSE:STVN) with a Neutral and lowers the price
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provide
On September 01, 2026, Stevanato Group SpA (STVN) shares fell 3.4% to a current price of $20.71, tra
Stevanato Group is transforming from a pharmaceutical glass supplier into an integrated drug contain
On August 28, 2026, Stevanato Group SpA (STVN) shares fell 5.7%, closing at $21.03. The stock has ex
Stevanato Group (NYSE: STVN) reported second-quarter 2026 revenue growth of 8% as demand for higher-
Stevanato Group NYSE: STVN reported second-quarter 2026 revenue growth of 8% as demand for higher-va
Stevanato (STVN) is well positioned to outperform the market, as it exhibits above-average growth in
Stevanato Group S.p.A. (STVN) Q2 2026 Earnings Call Transcript
Stevanato Group (NYSE:STVN) held its second-quarter earnings conference call on Tuesday. Below is th
Stevanato Group (STVN) came out with quarterly earnings of $0.16 per share, beating the Zacks Consen
Stevanato Group (NYSE:STVN) lowers FY2026 GAAP EPS guidance from $0.64-$0.69 to $0.62-$0.64. Lowers
Stevanato Group (NYSE:STVN) narrows FY2026 Adj EPS guidance from $0.69-$0.73 to $0.70-$0.72 vs $0.68
Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.16 per share which beat the analyst conse
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provide
The regulatory approvals cover therapies for diabetes and weight management, further expanding the c
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provide
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provide
Stevanato Group is reiterated as a Buy, driven by robust Q1 results and a compelling long-term growt
The shares of both stocks are down so far this year. Stevanato is benefiting from the need for GLP-1
PIOMBINO DESE, Italy--(BUSINESS WIRE)-- #DiabetesTherapies--Stevanato Group S.p.A. (NYSE: STVN), a l
U.S. stocks trade lower on Friday, Nasdaq down 425 points. Merlin shares rise 35.93% after successfu
Wolfe Research analyst Mike Polark assumes Stevanato Group (NYSE:STVN) with a Outperform rating a
Stevanato Group (NYSE:STVN) affirms FY2026 GAAP EPS guidance from $0.64-$0.69 to $0.64-$0.69. sees s
Stevanato Group (NYSE:STVN) affirms FY2026 Adj EPS guidance from $0.69-$0.73 to $0.69-$0.73 vs $0.70
Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.13 per share which beat the analyst conse
Morgan Stanley analyst Tejas Savant maintains Stevanato Group (NYSE:STVN) with a Equal-Weight and
Top performing mid-cap stocks in the last week, including Semtech, Stevanato, Ambarella, Ardent Heal
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the comp
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third q